ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
Ledermann, J.A., Matias-Guiu, X., Amant, F., Concin, N., Davidson, B., Fotopoulou, C., González-Martin, A., Gourley, C., Leary, A., Lorusso, D., Banerjee, S., Chiva, L., Cibula, D., Colombo, N., Croce, S., Eriksson, A.G., Falandry, C., Fischerova, D., Harter, P., Joly, F., Lazaro, C., Lok, C., Mahner, S., Marmé, F., Marth, C., McCluggage, W.G., McNeish, I.A., Morice, P., Nicum, S., Oaknin, A., Pérez-Fidalgo, J.A., Pignata, S., Ramirez, P.T., Ray-Coquard, I., Romero, I., Scambia, G., Sehouli, J., Shapira-Frommer, R., Sundar, S., Tan, D.S.P., Taskiran, C., van Driel, W.J., Vergote, I., Planchamp, F., Sessa, C., Fagotti, A.
Published in Annals of oncology (01.03.2024)
Published in Annals of oncology (01.03.2024)
Get full text
Journal Article
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial
Dinkic, C, Eichbaum, M, Schmidt, M, Grischke, E.M, Gebauer, G, Fricke, H.C, Lenz, F, Wallwiener, M, Marme, F, Schneeweiss, A, Sohn, C, Rom, J
Published in Gynecologic oncology (01.08.2017)
Published in Gynecologic oncology (01.08.2017)
Get full text
Journal Article
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
Schneeweiss, A., Marmé, F., Ruiz, A., Manikhas, A.G., Bottini, A., Wolf, M., Sinn, H.-P., Mansouri, K., Kennedy, L., Bauknecht, T.
Published in Annals of oncology (01.03.2011)
Published in Annals of oncology (01.03.2011)
Get full text
Journal Article
Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes
Fasching, P.A., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K., Schmatloch, S., Camara, O., Lück, H.J., Huober, J., Karn, T., van Mackelenbergh, M.T., Marme, F., Müller, V., Schem, C., Stickeler, E., Sahin, U., Loibl, S., Untch, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Final analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients
Reinisch, M., Seiler, S., Hauzenberger, T., Schmatloch, S., Strittmatter, H.-J., Zahm, D.-M., Thode, C., Jackisch, C., Strik, D., Moebus, V., Reimer, T., Sinn, B., Stickeler, E., Marme, F., Janni, W., Kamischke, A., Rudlowski, C., Nekljudova, V., von Minckwitz, G., Loibl, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)
Fasching, P.A., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K., Schmatloch, S., Camara, O., Lück, H.J., Huober, J., Karn, T., van Mackelenbergh, M.T., Marme, F., Müller, V., Schem, C., Stickeler, E., Sahin, U., Loibl, S., Untch, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer
Rom, J., von Minckwitz, G., Marmé, F., Ataseven, B., Kozian, D., Sievert, M., Schlehe, B., Schuetz, F., Scharf, A., Kaufmann, M., Sohn, C., Schneeweiss, A.
Published in Annals of oncology (01.11.2009)
Published in Annals of oncology (01.11.2009)
Get full text
Journal Article
Pooled analyses of eribulin in metastatic breast cancer patients with at least one prior chemotherapy
Pivot, X., Marmé, F., Koenigsberg, R., Guo, M., Berrak, E., Wolfer, A.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo
Karn, T., Denkert, C., Weber, K.E., Holtrich, U., Hanusch, C., Sinn, B.V., Higgs, B.W., Jank, P., Sinn, H.P., Huober, J., Becker, C., Blohmer, J.-U., Marmé, F., Schmitt, W.D., Wu, S., van Mackelenbergh, M., Müller, V., Schem, C., Stickeler, E., Fasching, P.A., Jackisch, C., Untch, M., Schneeweiss, A., Loibl, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
Hennigs, A., Riedel, F., Marmé, F., Sinn, P., Lindel, K., Gondos, A., Smetanay, K., Golatta, M., Sohn, C., Schuetz, F., Heil, J., Schneeweiss, A.
Published in Breast cancer research and treatment (01.12.2016)
Published in Breast cancer research and treatment (01.12.2016)
Get full text
Journal Article
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
Llop-Guevara, A., Loibl, S., Villacampa, G., Vladimirova, V., Schneeweiss, A., Karn, T., Zahm, D.-M., Herencia-Ropero, A., Jank, P., van Mackelenbergh, M., Fasching, P.A., Marmé, F., Stickeler, E., Schem, C., Dienstmann, R., Florian, S., Nekljudova, V., Balmaña, J., Hahnen, E., Denkert, C., Serra, V.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial
Pujade-Lauraine, E., Selle, F., Scambia, G., Asselain, B., Marmé, F., Lindemann, K., Colombo, N., Mądry, R., Glasspool, R., Vergote, I., Korach, J., Lheureux, S., Dubot, C., Oaknin, A., Zamagni, C., Heitz, F., Gladieff, L., Rubio-Pérez, M.J., Scollo, P., Blakeley, C., Shaw, B., Ray-Coquard, I., Redondo, A.
Published in Annals of oncology (01.12.2023)
Published in Annals of oncology (01.12.2023)
Get full text
Journal Article
Acid-type catalytic properties of heteropolyacid H3PW12O40 supported on various porous silica-based materials
MARME, F, COUDURIER, G, VEDRINE, J. C
Published in Microporous and mesoporous materials (17.06.1998)
Published in Microporous and mesoporous materials (17.06.1998)
Get full text
Journal Article
A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
Haense, N, Atmaca, A, Pauligk, C, Steinmetz, K, Marmé, F, Haag, G M, Rieger, M, Ottmann, O G, Ruf, P, Lindhofer, H, Al-Batran, S-E
Published in BMC cancer (07.07.2016)
Published in BMC cancer (07.07.2016)
Get full text
Journal Article
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer
Villegas, S. L., Darb-Esfahani, S., von Minckwitz, G., Huober, J., Weber, K., Marmé, F., Furlanetto, J., Schem, C., Pfitzner, B. M., Lederer, B., Engels, K., Kümmel, S., Müller, V., Mehta, K., Denkert, C., Loibl, S.
Published in Breast cancer research and treatment (01.02.2018)
Published in Breast cancer research and treatment (01.02.2018)
Get full text
Journal Article
FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer
Marmé, F., Werft, W., Benner, A., Burwinkel, B., Sinn, P., Sohn, C., Lichter, P., Hahn, M., Schneeweiss, A.
Published in Annals of oncology (01.08.2010)
Published in Annals of oncology (01.08.2010)
Get full text
Journal Article
Tailoring the dosing schedule of nab -paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of experts
Arpino, G, Marmé, F, Cortés, J, Ricevuto, E, Leonard, R, Llombart-Cussac, A
Published in Critical reviews in oncology/hematology (01.03.2016)
Published in Critical reviews in oncology/hematology (01.03.2016)
Get full text
Journal Article
Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials
Jank, P., Loibl, S., Fasching, P.A., Karn, T., Marmé, F., Mueller, V., Schem, C., Stickeler, E., Lederer, B., Denkert, C.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility
Sinn, P., Aulmann, S., Wirtz, R., Schott, S., Marmé, F., Varga, Z., Lebeau, A., Kreipe, H., Schneeweiss, A.
Published in Geburtshilfe und Frauenheilkunde (01.09.2013)
Published in Geburtshilfe und Frauenheilkunde (01.09.2013)
Get full text
Journal Article